Cargando…
What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?
Nonalcoholic steatohepatitis (NASH) can progress to cirrhosis and its complications, including hepatocellular carcinoma. Given that the majority of patients with NASH are asymptomatic, developing screening strategies to identify those individuals at risk for progressive NASH remains a highly unmet n...
Autores principales: | Alkhouri, Naim, Tincopa, Monica, Loomba, Rohit, Harrison, Stephen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557311/ https://www.ncbi.nlm.nih.gov/pubmed/34499435 http://dx.doi.org/10.1002/hep4.1814 |
Ejemplares similares
-
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis
por: Tincopa, Monica A.
Publicado: (2020) -
Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints
por: Alkhouri, Naim, et al.
Publicado: (2019) -
MRI‐Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis
por: Loomba, Rohit
Publicado: (2021) -
Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis
por: Sinakos, Emmanouil, et al.
Publicado: (2022) -
What does the future hold?
por: de Campos, Fernando Peixoto Ferraz
Publicado: (2012)